SurgLine Signs with MedPassage 3/27/2013
Newport Beach, CA -- Mar 27, 2013 / (www.myprgenie.com) -- SurgLine International, Inc., a premiere reseller and distributor of FDA approved stable technology for surgical implants and surgical instruments in the operating room, has executed a seller participation agreement on March 20, 2013 with MedPassage Inc. (medpassage.com) as a charter member of the MedPassage ecosystem. The Company will offer its full line of products that it sells to ambulatory surgery centers and hospitals through its affiliation with MedPassage at tremendous savings.
"The MedPassage ecosystem empowers medical centers and device companies to collaborate and exchange products more efficiently than ever before", said Tom Toland, CEO of Surgline International, Inc. "We are pleased to work alongside MedPassage and their talented executive management team and are anticipating a tremendous opportunity for SurgLine and its product offering."
Over the coming weeks and months, SurgLine and MedPassage will work closely to load its catalogs of FDA approved cost-effective surgical products onto the MedPassage ecosystem for sale to surgery centers, hospitals, Accountable Care Organizations and Physician Owned Distributors also known as POD's.
At SurgLine, we believe that the ability to level the playing field for both buyers and sellers of medical devices and medical and surgical products will be the way of the future, and SurgLine will be right there leading the way with MedPassage.com.
About SurgLine, Inc.
SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospitals, self-insured employers and insurance companies.
About SurgLine International, Inc.
SurgLine International, Inc. is a holding company that, in addition to SurgLine, wholly owns Nuvo Solar Energy, Inc.
This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.
Contact: Thomas Toland, ttoland@surgline.com, 949-698-8485
Category: Healthcare
Word Count:361
Tags: Surgline, Medpassage, surgical implants, surgical devices
Weblinks:
AI
